Takamichi Ito (T Ito)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Topics

Basal Cell Carcinoma

Atopic Dermatitis

Top Venues

The Journal of dermatology

Journal of clinical medicine

Cell death discovery

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoru Mizuhashi, Takamichi Ito, Takeo Maekawa, Shoichiro Ishizuki, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Koji Yoshino, Yasuhiro Fujisawa, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Satoshi Fukushima, Yoshihide Asano, Taku Fujimura
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes. Cancers 16 (15) (2024)
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoru Mizuhashi, Takamichi Ito, Takeo Maekawa, Shoichiro Ishizuki, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Koji Yoshino, Yasuhiro Fujisawa, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Satoshi Fukushima, Yoshihide Asano, Taku Fujimura
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes. Cancers 16 (15) (2024)
Taku Fujimura, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Shigeto Matsushita, Koji Yoshino, Yasuhiro Fujisawa, Shoichiro Ishizuki, Kojiro Segawa, Jun Yamamoto, Akira Hashimoto, Yumi Kanbayashi, Yoshihide Asano
Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases. The Journal of dermatology (2023)
Yuka Tanaka, Takamichi Ito, Yumiko Kaku-Ito, Keiko Tanegashima, Gaku Tsuji, Makiko Kido-Nakahara, Yoshinao Oda, Takeshi Nakahara
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma. Cell death discovery 9 (1) (2023)
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku-Ito, Yuka Tanaka, Takeshi Nakahara
Nail Apparatus Melanoma: Current Management and Future Perspectives. Journal of clinical medicine 12 (6) (2023)
Takamichi Ito, Yuka Tanaka, Toshio Ichiki, Yumiko Kaku-Ito, Takeshi Nakahara
KS-EMPD-1: a novel cell line of primary extramammary Paget's disease. Human cell (2023)
Yuka Tanaka, Takamichi Ito, Yumiko Kaku-Ito, Keiko Tanegashima, Gaku Tsuji, Makiko Kido-Nakahara, Yoshinao Oda, Takeshi Nakahara
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma. Cell death discovery 9 (1) (2023)
Yuka Tanaka, Takamichi Ito, Yumiko Kaku-Ito, Keiko Tanegashima, Gaku Tsuji, Makiko Kido-Nakahara, Yoshinao Oda, Takeshi Nakahara
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma. Cell death discovery 9 (1) (2023)
Yuka Tanaka, Takamichi Ito, Yumiko Kaku-Ito, Keiko Tanegashima, Gaku Tsuji, Makiko Kido-Nakahara, Yoshinao Oda, Takeshi Nakahara
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma. Cell death discovery 9 (1) (2023)
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku-Ito, Yuka Tanaka, Takeshi Nakahara
Nail Apparatus Melanoma: Current Management and Future Perspectives. Journal of clinical medicine 12 (6) (2023)
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, Makiko Kido-Nakahara, Takamichi Ito, Takeshi Nakahara
Regulatory Mechanism of the IL-33-IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis. International journal of molecular sciences 24 (19) (2023)
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, Makiko Kido-Nakahara, Takamichi Ito, Takeshi Nakahara
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis. Biomedicines 11 (5) (2023)
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku-Ito, Yuka Tanaka, Takeshi Nakahara
Nail Apparatus Melanoma: Current Management and Future Perspectives. Journal of clinical medicine 12 (6) (2023)
Anna Kamimura, Yasuhiro Nakamura, Tatsuya Takenouchi, Shigeto Matsushita, Toshikazu Omodaka, Kentaro Yamamura, Hiroshi Uchi, Shusuke Yoshikawa, Hiroto Yanagisawa, Takamichi Ito, Yoshio Kiyohara, Yoshio Nakamura, Megumi Aoki, Shoichiro Ishizuki, Kohei Oashi, Takuya Miyagawa, Taku Maeda, Dai Ogata, Naohito Hatta, Shuichi Ohe, Taiki Isei, Akira Takahashi, Yoshiyasu Umeda, Buntaro Yamaguchi, Masashi Ishikawa, Kohei Horimoto, Yasuhiro Fujisawa, Jiro Uehara, Yoshitsugu Shibayama, Yukiko Kiniwa, Yu Kawahara, Taisuke Matsuya, Hisashi Uhara, Junji Kato, Yoshiyuki Nakamura, Takuo Murakami, Kenjiro Namikawa, Koji Yoshino, Takeru Funakoshi, Sumiko Takatsuka, Yu Matsui, Jin Sasaki, Hiroshi Koga, Kenji Yokota, Takaya Komori, Satoshi Fukushima, Naoya Yamazaki
Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN). The Journal of dermatology 49 (9) (2022)
Takamichi Ito, Hiroki Hashimoto, Yuka Tanaka, Keiko Tanegashima, Maho Murata, Toshio Ichiki, Takeshi Iwasaki, Yoshinao Oda, Yumiko Kaku-Ito
TROP2 Expression in Sebaceous and Sweat Gland Carcinoma. Journal of clinical medicine 11 (3) (2022)
Takamichi Ito, Keiko Tanegashima, Yuka Tanaka, Hiroki Hashimoto, Maho Murata, Yoshinao Oda, Yumiko Kaku-Ito
Trop2 Expression in Extramammary Paget's Disease and Normal Skin. International journal of molecular sciences 22 (14) (2021)
A Yokoyama, Takamichi Ito, Masutaka Furue
Sudden and transient livedo reticularis as a manifestation of mononucleosis-like disease by cytomegalovirus. Clinical and experimental dermatology 46 (6) (2021)
Hiroki Hashimoto, Yumiko Kaku-Ito, Masutaka Furue, Takamichi Ito
The Outcome of Chemotherapy for Metastatic Extramammary Paget's Disease. Journal of clinical medicine 10 (4) (2021)
Hiroki Hashimoto, Takamichi Ito, Yuichi Yamada, Yoshinao Oda, Masutaka Furue
Onychopapilloma presenting as longitudinal melanonychia: A case report and literature review. The Australasian journal of dermatology 62 (2) (2021)
Hiroki Hashimoto, Takamichi Ito, Fumitaka Ohno, Hiromi Morisawa, Masutaka Furue
Severe drug eruption induced by cyclin-dependent kinase 4 and 6 inhibitor. The Journal of dermatology 48 (7) (2021)
Taketoshi Ide, Takamichi Ito, Maiko Wada-Ohno, Masutaka Furue
Preoperative Screening CT and PET/CT Scanning for Acral Melanoma: Is it Necessary? Journal of clinical medicine 10 (4) (2021)
Takamichi Ito, Yuka Tanaka, Maho Murata, Yumiko Kaku-Ito, Kazuhisa Furue, Masutaka Furue
BRAF Heterogeneity in Melanoma. Current treatment options in oncology 22 (3) (2021)
Yuka Tanaka, Maho Murata, Yoshinao Oda, Masutaka Furue, Takamichi Ito
Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target? Biomedicines 9 (4) (2021)
Asako Suenaga, Takamichi Ito, Ayaka Eto, Masutaka Furue
Acral ischemia induced by nivolumab: A case report. The Journal of dermatology 48 (5) (2021)
Yuka Tanaka, Maho Murata, Che-Hung Shen, Masutaka Furue, Takamichi Ito
NECTIN4: A Novel Therapeutic Target for Melanoma. International journal of molecular sciences 22 (2) (2021)
Hiroki Hashimoto, Takamichi Ito, Toshio Ichiki, Yuichi Yamada, Yoshinao Oda, Masutaka Furue
The Clinical and Histopathological Features of Cutaneous Immune-Related Adverse Events and Their Outcomes. Journal of clinical medicine 10 (4) (2021)
Hiroki Hashimoto, Takamichi Ito, Taketoshi Ide, Natsuki Sasaki, Shiori Hikichi, Masutaka Furue
Pyrexia by COVID-19 in a patient treated with dabrafenib/trametinib therapy. The Journal of dermatology 48 (2) (2020)
Hiroki Hashimoto, Takamichi Ito, Yuichi Yamada, Yoshinao Oda, Masutaka Furue
Eosinophilic infiltration discriminates lichen-planus-like eruption caused by an immune checkpoint inhibitor from ordinary lichen planus. The Journal of dermatology 48 (2) (2020)
Takamichi Ito, Yumiko Kaku-Ito, Maiko Wada-Ohno, Masutaka Furue
Narrow-Margin Excision for Invasive Acral Melanoma: Is It Acceptable? Journal of clinical medicine 9 (7) (2020)
Taku Fujimura, Koji Yoshino, Hiroshi Kato, Yasuhiro Fujisawa, Yoshiyuki Nakamura, Yuki Yamamoto, Kayo Kunimoto, Takamichi Ito, Shigeto Matsushita, Takeo Maekawa, Kentaro Ohuchi, Ryo Amagai, Yusuke Muto, Sadanori Furudate, Yumi Kanbayashi, Akira Hashimoto, Setsuya Aiba
Case series of BRAF-mutated advanced melanoma treated with encorafenib plus binimetinib combination therapy. The Journal of dermatology 48 (3) (2020)
Kazuhisa Furue, Dugarmaa Ulzii, Yuka Tanaka, Takamichi Ito, Gaku Tsuji, Makiko Kido-Nakahara, Takeshi Nakahara, Masutaka Furue
Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis. The Journal of dermatology 47 (9) (2020)
Maho Murata, Takamichi Ito, Yuka Tanaka, Yumiko Kaku-Ito, Masutaka Furue
NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target. International journal of molecular sciences 21 (16) (2020)
Kazuhisa Furue, Takamichi Ito, Gaku Tsuji, Hitokazu Esaki, Makiko Kido-Nakahara, Takeshi Nakahara, Masutaka Furue
Does mechanical scratching cause the recruitment of T-helper 17 cells in atopic dermatitis? The Journal of dermatology 46 (11) (2019)
Yasuhiro Nakamura, Jun Asai, Hiroshi Igaki, Takashi Inozume, Kenjiro Namikawa, Ayato Hayashi, Satoshi Fukushima, Taku Fujimura, Takamichi Ito, Keisuke Imafuku, Ryota Tanaka, Yukiko Teramoto, Akane Minagawa, Takuya Miyagawa, Azusa Miyashita, Makoto Wada, Hiroshi Koga, Makoto Sugaya
Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. The Journal of dermatology 47 (2) (2019)